The remainder of 2025 will be busy for Vir Biotechnology as it strives to successfully pivot to developing cancer and infectious disease therapies.

Net revenues of Euro 1,787 million, up 4.4% versus prior year, with total shipments of 3,494 unitsOperating profit (EBIT)(1) ...

The long-term nature of the automotive production cycle and product integration results in contract durations of 7-10 years, creating a significant switching cost to automotive OEMs. The narrow moat ...

"It doesn’t shine like gold nor smell like oil, but it’s worth more than both. And the countries that don’t control it will ...